German healthcare firm Siemens has formed a strategic collaboration with NuVasive to develop novel technologies for spine surgery procedures.
The two companies will jointly work on technology development and commercial activities to boost the clinical outcomes in minimally invasive spine surgeries.
Siemens will integrate NuVasive’s pulse surgical automation platform with its Cios Spin mobile 3D intraoperative imaging technology.
Based in the US, NuVasive specialises in providing spine technologies.
The transaction will enable the two companies to help surgeons and hospitals in improving operating room workflow efficiency and provide scalable, cost-effective technology.
Boston Scientific has entered an agreement to purchase Veniti for $160m.
Veniti will receive an up-front cash payment of $108m and $52m in contingent payments from Boston Scientific, upon the US FDA approval of the former’s VICI stent system.
The VICI venous stent system developed by Veniti is a self-expanding device designed for use in the venous anatomy, as well as to withstand compression and maintain flexibility throughout a patient’s lifespan.
Based in the US, Boston Scientific is a manufacturer of medical devices for use in various interventional medical specialties, while Veniti, also based in the US, is a provider of medical devices used for the treatment of the venous disease.
The transaction will bolster the acquirer company’s venous therapies portfolio within its peripheral interventions division.
Gooch and Housego has acquired UK-based medical and in-vitro diagnostic devices manufacturer, Integrated Technologies Ltd, for an undisclosed sum.
Based in the UK, G&H specialises in the design and manufacture of photonic systems, components, and instrumentation.
The acquisition enables Gooch and Housego to expand its presence in the life and health sciences sector and provide access to new, rapidly growing markets. It will also enable the company to develop innovative solutions that meet the customer’s demands.